Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

[Regulation of innovations in the field of e-health].

Fagon JY.

Med Sci (Paris). 2018 May;34 Hors série n°1:36. doi: 10.1051/medsci/201834s119. Epub 2018 Jun 18. French. No abstract available.

2.

How to strengthen the presence of patients in health technology assessments conducted by the health authorities.

Mamzer MF, Dubois S, Saout C; participants of Round Table «Topical Subject» of Giens XXXIII, Albin N, Béhier JM, Buisson A, Diebolt V, Delaitre O, Duguet C, Fagon JY, Gaillard S, Le Jeunne C, Mazars R, Micallef J, Nabarette H, Piazza L, Raynaud C, Varoqueaux N.

Therapie. 2018 Feb;73(1):95-105. doi: 10.1016/j.therap.2017.11.004. Epub 2017 Dec 21. French.

PMID:
29478707
3.

Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes.

Aissaoui N, Morshuis M, Maoulida H, Salem JE, Lebreton G, Brunn M, Chatellier G, Hagège A, Schoenbrodt M, Puymirat E, Latremouille C, Varnous S, Ouldamar S, Guillemain R, Diebold B, Guedeney P, Barreira M, Mutuon P, Guerot E, Paluszkiewicz L, Hakim-Meibodi K, Schulz U, Danchin N, Gummert J, Durand-Zaleski I, Leprince P, Fagon JY.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):170-177. doi: 10.1093/ejcts/ezx258.

PMID:
28950304
4.

Outcomes in elderly patients admitted to the intensive care unit with solid tumors.

Auclin E, Charles-Nelson A, Abbar B, Guérot E, Oudard S, Hauw-Berlemont C, Thibault C, Monnier A, Diehl JL, Katsahian S, Fagon JY, Taieb J, Aissaoui N.

Ann Intensive Care. 2017 Dec;7(1):26. doi: 10.1186/s13613-017-0250-0. Epub 2017 Mar 6.

5.

Right-left ventricular interdependence: a promising predictor of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock.

Aissaoui N, Caudron J, Leprince P, Fagon JY, Lebreton G, Combes A, Diebold B.

Intensive Care Med. 2017 Apr;43(4):592-594. doi: 10.1007/s00134-016-4657-0. Epub 2016 Dec 23. No abstract available.

PMID:
28011989
6.

Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997-2012.

Puymirat E, Fagon JY, Aegerter P, Diehl JL, Monnier A, Hauw-Berlemont C, Boissier F, Chatellier G, Guidet B, Danchin N, Aissaoui N; Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa Group [Intensive Care Database User Group]).

Eur J Heart Fail. 2017 Feb;19(2):192-200. doi: 10.1002/ejhf.646. Epub 2016 Oct 6.

7.

Ilio-psoas hematoma in the intensive care unit: a multicentric study.

Llitjos JF, Daviaud F, Grimaldi D, Legriel S, Georges JL, Guerot E, Bedos JP, Fagon JY, Charpentier J, Mira JP.

Ann Intensive Care. 2016 Dec;6(1):8. doi: 10.1186/s13613-016-0106-z. Epub 2016 Jan 19.

8.

Treatment intensity, age and outcome in medical ICU patients: results of a French administrative database.

Peigne V, Somme D, Guérot E, Lenain E, Chatellier G, Fagon JY, Saint-Jean O.

Ann Intensive Care. 2016 Dec;6(1):7. doi: 10.1186/s13613-016-0107-y. Epub 2016 Jan 14.

9.

Daily FOUR score assessment provides accurate prognosis of long-term outcome in out-of-hospital cardiac arrest.

Weiss N, Venot M, Verdonk F, Chardon A, Le Guennec L, Llerena MC, Raimbourg Q, Taldir G, Luque Y, Fagon JY, Guerot E, Diehl JL.

Rev Neurol (Paris). 2015 May;171(5):437-44. doi: 10.1016/j.neurol.2015.02.013. Epub 2015 Apr 22.

PMID:
25912282
10.

Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables.

Aissaoui N, Salem JE, Paluszkiewicz L, Morshuis M, Guerot E, Gorria GM, Fagon JY, Gummert J, Diebold B.

Arch Cardiovasc Dis. 2015 May;108(5):300-9. doi: 10.1016/j.acvd.2015.01.011. Epub 2015 Apr 8.

11.

Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondes.

Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; participants of round table N°3 of Giens XXX:, Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C; 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé.

Therapie. 2015 Jan-Feb;70(1):37-55. doi: 10.2515/therapie/2015003. Epub 2015 Feb 16. Review. English, French.

PMID:
25679193
12.

Biosimilars: from Technical to Pharmacoeconomic Considerations.

Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; participants of round table N°3 of Giens XXX:, Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C.

Therapie. 2015 Jan-Feb;70(1):47-55. doi: 10.2515/therapie/2015003.

PMID:
27393396
13.

Biosimilaires : de la technique au médicoéconomique.

Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; et les participants à la table ronde N°3 de Giens XXX :, Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C.

Therapie. 2015 Jan-Feb;70(1):37-46. doi: 10.2515/therapie/2014233. French. No abstract available.

PMID:
27393395
14.

Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients.

Gey A, Tadie JM, Caumont-Prim A, Hauw-Berlemont C, Cynober L, Fagon JY, Terme M, Diehl JL, Delclaux C, Tartour E.

Clin Exp Immunol. 2015 May;180(2):280-8. doi: 10.1111/cei.12567.

15.

Methicillin-resistant Staphylococcus aureus bloodstream infections are associated with a higher energy deficit than other ICU-acquired bacteremia.

Ekpe K, Novara A, Mainardi JL, Fagon JY, Faisy C.

Intensive Care Med. 2014 Dec;40(12):1878-87. doi: 10.1007/s00134-014-3502-6. Epub 2014 Oct 7.

PMID:
25288210
16.

Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results.

Dervaux B, Baseilhac E, Fagon JY; participants of round table n4 of Giens XXIX : Biot Claire 4 Blachier Corinne 5 Braun Eric 6 Debrou, Biot C, Blachier C, Braun E, Debroucker F, Detournay B, Ferretti C, Granger M, Jouan-Flahault C, Lussier MD, Meyer A, Muller S, Pigeon M, De Sahb R, Sannié T, Sapède C, Vray M.

Therapie. 2014 Jul-Aug;69(4):323-8. doi: 10.2515/therapie/2014048. Epub 2014 Aug 12. English, French.

PMID:
25230355
17.

Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis.

Mangin O, Urien S, Mainardi JL, Fagon JY, Faisy C.

Clin Pharmacokinet. 2014 Sep;53(9):849-61. doi: 10.1007/s40262-014-0164-z.

PMID:
25117184
18.

Impact of inodilator drugs on echocardiographic assessments of left ventricular filling pressure in patients with decompensated end-stage heart failure*.

Salem JE, Aissaoui N, Paluszkiewicz L, Morshuis M, Gummert J, Leprince P, Fagon JY, Hulot JS, Diebold B.

Crit Care Med. 2014 Dec;42(12):2508-17. doi: 10.1097/CCM.0000000000000513.

PMID:
25083976
19.

Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.

Kollef MH, Chastre J, Fagon JY, François B, Niederman MS, Rello J, Torres A, Vincent JL, Wunderink RG, Go KW, Rehm C.

Crit Care Med. 2014 Oct;42(10):2178-87. doi: 10.1097/CCM.0000000000000510.

PMID:
25054674
20.

Évaluation médico-économique des produits de santé. Méthodologie pour la définition d'un impact significatif sur les dépenses de l'Assurance maladie et choix des référentiels pour l'interprétation des résultats.

Dervaux B, Baseilhac E, Fagon JY; et les participants à la table ronde N°4 de Giens XXIX :, Biot C, Blachier C, Braun E, Debroucker F, Detournay B, Ferretti C, Granger M, Jouan-Flahault C, Lussier MD, Meyer A, Muller S, Pigeon M, De Sahb R, Sannié T, Sapède C, Vray M.

Therapie. 2014 Jul-Aug;69(4):323-30. doi: 10.2515/therapie/2014046. French. No abstract available.

PMID:
27393226
21.

Comparison of intensive-care-unit-acquired infections and their outcomes among patients over and under 80 years of age.

Maillet JM, Guérot E, Novara A, Le Guen J, Lahjibi-Paulet H, Kac G, Diehl JL, Fagon JY.

J Hosp Infect. 2014 Jul;87(3):152-8. doi: 10.1016/j.jhin.2014.03.011. Epub 2014 Apr 29.

PMID:
24856114
22.

Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling.

Grohs P, Podglajen I, Guerot E, Bellenfant F, Caumont-Prim A, Kac G, Tillecovidin B, Carbonnelle E, Chatellier G, Meyer G, Fagon JY, Gutmann L.

Clin Microbiol Infect. 2014 Nov;20(11):O879-86. doi: 10.1111/1469-0691.12663. Epub 2014 Jul 25.

23.

Mediastinitis due to Gram-negative bacteria is associated with increased mortality.

Charbonneau H, Maillet JM, Faron M, Mangin O, Puymirat E, Le Besnerais P, Du Puy-Montbrun L, Achouh P, Diehl JL, Fagon JY, Mainardi JL, Guerot E.

Clin Microbiol Infect. 2014 Mar;20(3):O197-202. doi: 10.1111/1469-0691.12369. Epub 2013 Oct 30.

24.

Severe excessive dynamic airway collapse in a patient with primary Sjögren's syndrome.

Ismael S, Wermert D, Dang-Tran KD, Venot M, Fagon JY, Diehl JL.

Respir Care. 2014 Oct;59(10):e156-9. doi: 10.4187/respcare.02929. Epub 2013 Dec 31.

25.

Paradoxical effects of positioning in patients with ARDS and preexisting pulmonary vasculitis or similar disorders.

Diehl JL, Lortat-Jacob B, Lachaussée N, Aissaoui N, Venot M, Guérot E, Fagon JY.

Am J Respir Crit Care Med. 2013 Oct 1;188(7):875-7. doi: 10.1164/rccm.201302-0254LE. No abstract available.

PMID:
24083865
26.

Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.

Dervaux B, Baseilhac E, Fagon JY; participants of round table N°6 of Giens Workshops XXVIII (th), Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A.

Therapie. 2013 Jul-Aug;68(4):253-63. doi: 10.2515/therapie/2013045. Epub 2013 Aug 28. English, French.

27.

L'évaluation médico-économique des produits de santé dans le contexte de la loi de financement de la Sécurité sociale pour 2012.

Dervaux B, Baseilhac E, Fagon JY; les participants à la table ronde N°6 de Giens XXVIII :, Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A.

Therapie. 2013 Jul-Aug;68(4):253-7. doi: 10.2515/therapie/2013044. French. No abstract available.

PMID:
27392727
28.

Arginine administration to critically ill patients with a low nitric oxide fraction in the airways: a pilot study.

Tadié JM, Cynober L, Peigne V, Caumont-Prim A, Neveux N, Gey A, Guerot E, Diehl JL, Fagon JY, Tartour E, Delclaux C.

Intensive Care Med. 2013 Sep;39(9):1663-5. doi: 10.1007/s00134-013-2984-y. Epub 2013 Jun 19. No abstract available.

PMID:
23778831
29.

Impact of organizational culture on preventability assessment of selected adverse events in the ICU: evaluation of morbidity and mortality conferences.

Pelieu I, Djadi-Prat J, Consoli SM, Cariou A, Guidet B, You-Harada C, Paget V, Héraud G, Lefur C, Massin A, Hennequin M, Durieux P, Fagon JY, Faisy C.

Intensive Care Med. 2013 Jul;39(7):1214-20. doi: 10.1007/s00134-013-2923-y. Epub 2013 Apr 12.

PMID:
23580135
30.

Assessment of body cell mass at bedside in critically ill patients.

Savalle M, Gillaizeau F, Maruani G, Puymirat E, Bellenfant F, Houillier P, Fagon JY, Faisy C.

Am J Physiol Endocrinol Metab. 2012 Aug 1;303(3):E389-96. doi: 10.1152/ajpendo.00502.2011. Epub 2012 May 29.

31.

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.

François B, Luyt CE, Dugard A, Wolff M, Diehl JL, Jaber S, Forel JM, Garot D, Kipnis E, Mebazaa A, Misset B, Andremont A, Ploy MC, Jacobs A, Yarranton G, Pearce T, Fagon JY, Chastre J.

Crit Care Med. 2012 Aug;40(8):2320-6. doi: 10.1097/CCM.0b013e31825334f6.

PMID:
22622405
32.

Drowning after falling from a medium-height bridge: multiple trauma victims.

Heming N, Serve E, Weiss N, Imbert A, Ducharne G, Diehl JL, Guérot E, Fagon JY, Tadié JM.

Prehosp Emerg Care. 2012 Jul-Sep;16(3):356-60. doi: 10.3109/10903127.2012.670691. Epub 2012 Apr 11.

PMID:
22494150
33.

[Medicoeconomic data on rare disease drugs: a move towards more transparency?].

Schwebig A, Duguet C, Ferry A, Bougé C, Fagon JY, Bismuth C, Ramon J.

Presse Med. 2012 May;41 Suppl 1:S57-64. doi: 10.1016/j.lpm.2012.02.024. Epub 2012 Apr 8. French. No abstract available.

PMID:
22487716
34.

Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support.

Aissaoui N, Guerot E, Combes A, Delouche A, Chastre J, Leprince P, Leger P, Diehl JL, Fagon JY, Diebold B.

J Am Soc Echocardiogr. 2012 Jun;25(6):632-40. doi: 10.1016/j.echo.2012.02.009. Epub 2012 Mar 14.

PMID:
22421027
35.

Causes of coma and their evolution in the medical intensive care unit.

Weiss N, Regard L, Vidal C, Luque Y, Taldir G, Vallet H, Diehl JL, Fagon JY, Guerot E.

J Neurol. 2012 Jul;259(7):1474-7. doi: 10.1007/s00415-011-6388-z. Epub 2012 Jan 10. No abstract available.

PMID:
22231871
36.

Drowning associated pneumonia: a descriptive cohort.

Tadié JM, Heming N, Serve E, Weiss N, Day N, Imbert A, Ducharne G, Faisy C, Diehl JL, Safran D, Fagon JY, Guérot E.

Resuscitation. 2012 Mar;83(3):399-401. doi: 10.1016/j.resuscitation.2011.08.023. Epub 2011 Sep 10.

PMID:
21907690
37.

Early ICU energy deficit is a risk factor for Staphylococcus aureus ventilator-associated pneumonia.

Faisy C, Candela Llerena M, Savalle M, Mainardi JL, Fagon JY.

Chest. 2011 Nov;140(5):1254-1260. doi: 10.1378/chest.11-1499. Epub 2011 Sep 8.

PMID:
21903738
39.

Can fast-component of nystagmus on caloric vestibulo-ocular responses predict emergence from vegetative state in ICU?

Weiss N, Tadie JM, Faugeras F, Diehl JL, Fagon JY, Guerot E.

J Neurol. 2012 Jan;259(1):70-6. doi: 10.1007/s00415-011-6120-z. Epub 2011 Jun 12.

PMID:
21667223
40.

Biological markers and diagnosis of ventilator-associated pneumonia.

Fagon JY.

Crit Care. 2011;15(2):130. doi: 10.1186/cc10050. Epub 2011 Mar 9.

41.

Non-invasive positive pressure ventilation (NIPPV)-induced pneumocephalus and pneumoperitoneum in a patient with a one-way flow control ventriculoperitoneal shunt.

Wolfromm A, Weiss N, Espinoza S, Diehl JL, Fagon JY, Guerot E.

Intensive Care Med. 2011 May;37(5):889-90. doi: 10.1007/s00134-011-2191-7. Epub 2011 Feb 26. No abstract available.

PMID:
21359607
42.

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.

Rubinstein E, Lalani T, Corey GR, Kanafani ZA, Nannini EC, Rocha MG, Rahav G, Niederman MS, Kollef MH, Shorr AF, Lee PC, Lentnek AL, Luna CM, Fagon JY, Torres A, Kitt MM, Genter FC, Barriere SL, Friedland HD, Stryjewski ME; ATTAIN Study Group.

Clin Infect Dis. 2011 Jan 1;52(1):31-40. doi: 10.1093/cid/ciq031. Erratum in: Clin Infect Dis. 2019 Mar 5;68(6):1070.

43.

A urinary cause of coma.

Weiss N, Levi C, Hussenet C, Karras A, Sedel F, Espinoza S, Savalle M, Pelieu I, Fagon JY, Guerot E, Diehl JL.

J Neurol. 2011 May;258(5):941-3. doi: 10.1007/s00415-010-5850-7. Epub 2010 Dec 7. No abstract available.

PMID:
21136271
44.

Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.

Venot M, Weiss N, Espinoza S, Imbert A, Tadie JM, Fagon JY, Guerot E, Diehl JL.

Intensive Care Med. 2011 Jan;37(1):177-9. doi: 10.1007/s00134-010-2055-6. Epub 2010 Sep 25. No abstract available.

PMID:
20871977
45.

[Acute respiratory distress syndrome due to Toxocara cati infection].

Tadié JM, Chaudeurge A, Lerolle N, Audibert J, Novara A, Fagon JY, Guérot E.

Rev Mal Respir. 2010 May;27(5):505-8. doi: 10.1016/j.rmr.2010.03.014. French.

PMID:
20569885
46.

Post-intubation laryngeal injuries and extubation failure: a fiberoptic endoscopic study.

Tadié JM, Behm E, Lecuyer L, Benhmamed R, Hans S, Brasnu D, Diehl JL, Fagon JY, Guérot E.

Intensive Care Med. 2010 Jun;36(6):991-8. doi: 10.1007/s00134-010-1847-z. Epub 2010 Mar 18.

PMID:
20237758
47.

Partitioning of exhaled NO in ventilated patients undergoing cardiac surgery.

Tadié JM, Zegdi R, Trinquart L, Kurdi O, Journois D, Latremouille C, Diehl JL, Louis B, Fagon JY, Fabiani JN, Delclaux C.

Respir Physiol Neurobiol. 2010 Apr 30;171(2):151-6. doi: 10.1016/j.resp.2010.02.010. Epub 2010 Feb 26.

PMID:
20219698
48.

Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation.

Faisy C, Mokline A, Sanchez O, Tadié JM, Fagon JY.

Intensive Care Med. 2010 May;36(5):859-63. doi: 10.1007/s00134-010-1795-7. Epub 2010 Mar 9.

PMID:
20217045
49.

Impact of morbidity and mortality conferences on analysis of mortality and critical events in intensive care practice.

Ksouri H, Balanant PY, Tadié JM, Heraud G, Abboud I, Lerolle N, Novara A, Fagon JY, Faisy C.

Am J Crit Care. 2010 Mar;19(2):135-45; quiz 146. doi: 10.4037/ajcc2010590.

50.

Prediction of nosocomial infection acquisition in ventilated patients by nasal nitric oxide: proof-of-concept study.

Tadié JM, Trinquart L, Jannière-Nartey C, Guerot E, Louis B, Fagon JY, Diehl JL, Delclaux C.

Shock. 2010 Sep;34(3):217-21. doi: 10.1097/SHK.0b013e3181d67494.

PMID:
20160667

Supplemental Content

Loading ...
Support Center